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Maddy Pearson and Clare Chandler
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK
ABSTRACT
Background: Antimicrobial resistance (AMR) is a growing global problem. Raising awareness
is central to global and national action plans to address AMR in human and livestock sectors.
Evidence on the best ways to reduce antibiotic use, and the impact of awareness raising
activities is mixed. This paucity of evidence is acute in Low-Middle-Income Country (LMIC)
settings, where healthcare professionals who prescribe and dispense antimicrobial medicines
are often assumed to have limited awareness of AMR and limited knowledge of the optimum
use of antimicrobials.
Objectives: This research aimed to explore AMR awareness among human and animal
healthcare professionals and the contextual issues influencing the relationship between
awareness and practices of antimicrobial prescribing and dispensing across different LMIC
settings.
Methods: Qualitative interviews and field observations were undertaken in seven study sites
in Ethiopia, India, Nigeria, the Philippines, Sierra Leone and Vietnam. Data included transcripts
from interviews with 244 purposively sampled healthcare professionals, analysed for cross-
cutting themes.
Results: AMR awareness was high among human and animal healthcare professionals. This
awareness of AMR did not translate into reduced prescribing and dispensing; rather, it linked
to the ready use of next-line antibiotics. Contextual factors that influenced prescribing and
dispensing included antibiotic accessibility and affordability; lack of local antibiotic sensitivity
information; concerns over hygiene and sanitation; and interaction with medical
representatives.
Conclusions: The high awareness of AMR in our study populations did not translate into
reduced antibiotic prescribing. Contextual factors such as improved infrastructure, informa-
tion and regulation seem essential for reducing reliance on antibiotics.
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Background
Antimicrobial Resistance (AMR) is a global problem
[1], rising in both biological prevalence and global
health strategy prominence [2]. Resistance to antimi-
crobial medicines can be seen across both human and
animal populations, linked to their increasing con-
sumption for medical purposes of disease treatment
[3] and their use as growth promoters in livestock
husbandry and agriculture [4–6]. One cornerstone of
global and national action plans to address AMR is to
raise awareness [1]; however, focus on awareness
building occurs at different priority levels in different
country settings. Evidence on the best ways to reduce
antibiotic use, and the impact of awareness raising
activities is mixed [1,7–9]. A major focus of existing
attempts has been on the ‘misuse’ of antibiotics for
self-limiting conditions such as coughs, colds and
viral upper-respiratory tract infections (URIs)
[10,11]. This narrative centres on the ‘front line’ of
medical practice; most notably healthcare profes-
sionals who prescribe and dispense antimicrobials
such as antibiotics, as well as patients who are
described as ‘demanding’ antimicrobials [12]. Across
High-Income Countries (HICs) this ‘misuse’ is pur-
ported to reflect the hierarchy and habitus [13] of
medical professionals [14,15] and their concerns over
the safety of patients if antimicrobials are not pre-
scribed [16]. In Low-Middle-Income Countries
(LMICs) ‘non-judicious’ practices of antimicrobial
prescribing and dispensing [17] have more often
been assumed to reflect a lack of awareness of AMR
and a lack of knowledge on the optimum use of
antimicrobials, including antimalarials and antibiotics
[18]. Despite being charged with irrational medicines
use, there remains little empirical work that attends
to what prescribers and dispensers across LMICs
think, know, and do in relation to AMR and anti-
microbials [19].
The dearth of information on how healthcare pro-
fessionals prescribe and dispense antimicrobials
across LMIC settings is an important research gap
[20], and moreover the ways that this relates to
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awareness of AMR must be understood in context if
successful strategies to quell AMR are to be developed
and implemented [21–23]. This article presents find-
ings from a multi-country study on AMR awareness
and practice among human and animal healthcare
professionals.
Methods
Ethics
This research was conducted in accordance with the
Declaration of Helsinki and national and institutional
standards. For each study site, ethical approval was
obtained from the London School of Hygiene and
Tropical Medicine and the relevant in-country ethics
board. Ministry of Health and Human Services Kaduna
State: MOH/ADM/744/VOL.1/539, LSHTM: 13717
(Nigeria); The Liver Foundation Trust, LSHTM: 14048
(West Bengal Veterinary); Indian Centre for Media
Studies Institutional Review Board: 1R800006230,
LSHTM: 13696 (West Bengal Human); The Sierra
Leone Ethics and Scientific Review Committee
Freetown: letter dated 30 May 2017, LSHTM: 13807
(Sierra Leone); Addis Ababa Regional Health Bureau:
A/A/H/B/7988/277, LSHTM: 13664 (Ethiopia); School
of Pharmacy at Addis Ababa University (AAU),
LSHTM: 13648 (Ethiopia); SRM Medical College
Hospital and Research Centre: 1218/IEC/2017,
LSHTM: 12262-1 (Chennai); WPRO 2017.16. PHL. 3.
EMT, LSHTM: 13439 (Philippines); National Hospital
for Tropical Diseases Scientific and Ethical Review
Board, LSHTM: 13631 (Vietnam).
Data collection and analysis
In-depth interviews and rapid ethnographic observa-
tion were undertaken with healthcare professionals in
seven study sites across six LMICs, aiming to under-
stand awareness of AMR and the relationships
between awareness, context and antimicrobial use.
Five of the study sites included interviews with
human practitioners only, two of the study sites
included interviews with human and veterinary prac-
titioners (Table 1).
Inclusion criteria for the study required practi-
tioners to be registered prescribers and/or dispensers
of antimicrobial medicines. This research does not
address AMR awareness and antimicrobial use
among unregistered practitioners who are known to
play a prominent role in the provision of antimicro-
bials across many LMIC settings [6]. The relevance of
the research is therefore to the sections of healthcare
services provided by trained healthcare professionals,
whom we anticipate will have different and more
standardised background training relevant to AMR
and antimicrobials than the range of untrained pro-
viders in many settings.
Participants were selected using purposive sampling
and subsequent snowball sampling aligned with the
inclusion criteria. The sample aimed to include antimi-
crobial prescribing and/or dispensing doctors, nurses,
dentists, pharmacists, medical educators and veterinar-
ians. Research took place in urban or semi-urban set-
tings; therefore, the study does not represent AMR
awareness and antimicrobial practice by healthcare pro-
fessionals in rural areas. All potential participants were
invited to join the study through a written informed
consent process which included permission to conduct,
record and transcribe interviews. If participants
declined to be recorded, with agreement the researcher
took written notes. Interviews comprised the primary
method of data collection, however researchers also
carried out observations.
Each researcher was based with an in-country
research institution (see ethical approval codes for
names of institutions) who helped researchers identify
and recruit potential participants. Researchers intended
to interview as many participants as possible until
saturation was reached. Constraints to recruitment
included time constraints of researchers in identifying
and scheduling interviews within a six-to-eight week
duration, difficulty identifying large numbers of animal
healthcare practitioners, and adverse weather condi-
tions (monsoon/rainy season) which limited travel
and negatively impacted interview schedules.
Researchers utilised a flexible participant-led
approach to data collection, using pre-prepared ques-
tions, structured around a pre-determined set of
topics as a guide, but trying where possible to follow
the narrative of participants, attending to important
contextual insights and not just to what individuals
‘knew’ about AMR.
Following collection, interview data were transcribed,
and translated where relevant. Field notes were typed up
from researcher observations. These materials were then
subject to thematic analysis [24]. Transcripts were
reviewed line by line, together with fieldnotes.
Responses to core questions on awareness and knowl-
edge were coded in a structured way to enable compara-
tive analysis between respondents. The narrative from
Table 1. Samples across study sites.
Country Region
Type of healthcare
practitioner
Number of
participants
interviewed
Vietnam Hanoi Human 24
Nigeria Abuja Human and animal 24
India West Bengal Human and animal 27
Chennai Human 30
Philippines Manila Human 61
Ethiopia Addis Ababa Human 67
Sierra Leone Freetown Human 11
Total All All 244
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each respondent was then reviewed, to understand the
ways they talked about resistance and antibiotic use in
their practice. These narratives were then considered on
a setting by setting basis, together with observation field-
notes and photographs of the study context, in order to
develop key themes for each setting. These themes were
then revisited in a cross-setting analysis, involving dialo-
gue with the primary data collectors as well as direct
analysis of the materials, to draw out points of salience
across settings and points of divergence. Four broad
themes that emerged in this cross-setting analysis are
explored in the results and discussion sections that fol-
low. Quotes are anonymised and participant IDs reflect
vocation (DXX doctor, DTXX dentist, NXX nurse, PXX
pharmacist, EDXX educator, VXX Veterinarian). Data
collection took place between May and July 2017. Data
analysis was undertaken during July and August. Cross-
setting analysis took place during September 2017.
Results
In all, 244 healthcare professionals participated in the
study including doctors (124) (general practice and
surgical, hospital and community health facility
based), pharmacists (70) (hospital and shop based),
a dentist (1), nurses (3), medical educators (33) and
veterinarians (13). The sample included professionals
spanning the public and private sector, a boundary
which appeared to be highly fluid, with many profes-
sionals working within both sectors either currently
or previously. A majority were based in urban or
peri-urban practices, reflecting the density of health-
care professionals in the selected countries. However,
the aesthetic differences both across and within study
sites were striking. From hospital doctors’ offices in
West Bengal, lined with artworks gifted by medical
representatives to nearby make-shift veterinary out-
houses, tin fronted ad hoc pharmacy shops in the
Philippines adorned with glass display cabinets of
antimicrobials, hospital consultation rooms in
Vietnam with bare metal bed frames and wall
mounted fans attempting to circulate the humid air;
the study sites captured the overwhelming material
and phenomenological diversity in medical provision
and practice all of which had profound implications,
influencing how interviewees understood or dis-
played awareness of AMR. Interviewees ranged in
age, included male and female participants and com-
prised medical trainees all the way through to late
career professionals.
Taken together, the study sites indicate high levels of
awareness of AMR and several cross-site recurring fac-
tors that influence antimicrobial use practices, includ-
ing infrastructural issues of lacking diagnostics,
availability of antimicrobials and shortages of medical
staff, social issues such as affordability of antimicrobials,
high levels of concern over poor hygiene and sanitation
in both clinical and communal settings, and finally
influential interactions with medical representatives
that condition selection of antimicrobials.
AMR awareness in practice
‘One of the problems we are facing in Nigeria, we use
the broad-spectrum antibiotics, and so … it‘s not
supposed to be like that, it‘s preferable, there‘s one
article I read … WHO standard, that you are sup-
posed to use a narrow-spectrum antibiotics… go for
a specific antibiotics that will target that agent, but
we go for broad-spectrum because these labs are not
available.‘ V007 – Nigeria
‘I would rather over-treat and risk the resistance
because there is indoor cooking the environment is
not good there is malnutrition… so I would rather
give antibiotics knowing that respiratory tract infec-
tion which is viral because I have no other way to
treat.’ D008 – Ethiopia
Awareness of AMR across the study sites was high:
almost all (99%) referred to resistance spontaneously or
demonstrated knowledge of resistance in their responses.
Most reported recognising AMR through treatment fail-
ure, for example symptoms failing to subside after anti-
biotic treatment or recurring illness episodes despite
antibiotic treatment as indicative of resistance:
‘During the treatment we will come to know, for
example lower generation antibiotic we are giving
and still infection is not clearing, symptoms are still
not suppressed then we will know that it may be
resistance.’ ED006 – Chennai
Interviewees across the study sites also demonstrated
knowledge of a variety of driving forces contributing
to the growing prevalence of AMR, including the use
of antibiotics for viral infections, inadequate dosing
and duration of antibiotic medicines and the usage of
substandard antibiotics – including contraband anti-
biotics and antibiotics used beyond their expiry date,
or those stored in unsuitable conditions.
The way AMR awareness was enacted in practice
included tailoring prescribing to anticipated resistance
profiles within the limits of working contexts which
included a lack of laboratory facilities for performing
culture and sensitivity testing, a lack of antibiotics to
choose from within the healthcare setting, and a short-
age of medical staff. In some cases, being aware of
potential resistance meant presumptive next-line ther-
apy, particularly if the patient could afford to pay:
‘I have seen many cases here in Medicine department
where meropenem is being given. Where the patient is
suspected to have septicaemia theremeropenem is being
given. And giving macrolides like ceftriaxone, cefurox-
ime [sic – these antibiotics are classified as cephalospor-
ins rather than macrolides] is most common in the
wards. It is not like that they started from lower anti-
biotics because we know that lower antibiotics will not
work because resistance has already been developed here
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and since the wards are so much dirty so it is quite
obvious that lower antibiotics will not work here in
this ward. So from the very beginning only we start
from higher antibiotics.’ D019 – West Bengal
The absence of information about local resistance
patterns was lamented and interviewees stated that
this contributed to a disorganised and irregular way
of constructing medical care in cases where patients
did not respond to antimicrobial treatment.
Respondents were keen to improve availability of
guidelines on antimicrobial prescribing and dispen-
sing that were relevant to their own setting, and the
sensitivity profiles of bacteria in their settings.
Pragmatic prescribing
‘If I prescribe Augmentin for them, I think I’m not
fair to that individual, bearing in mind that there are
a lot of adulterated, fake Augmentin in circulation so
I looked around, what are the best ones that doesn’t
(have) a lot of adulterated drugs and probably
cheaper? I will look for the other one that’s a bit
cheaper and usually it is not being adulterated…
usually pharmaceutical doesn’t fake Septrin, so I
will rather start with that Septrin.’ D002 – Nigeria
Tailoring prescribing according to potential resis-
tance was one of many considerations for our parti-
cipants. Both human and veterinary healthcare
professionals related pragmatic practice in use of
antibiotics, sensitive to economic, political and status
issues relating to systems, patients and the medicines
themselves. The lack of availability of antimicrobials
led practitioners across the study sites to rely on a
narrow set of antibiotics, prescribing and/or dispen-
sing what was available in their setting. The type of
antimicrobial selected was also dictated by perceived
patient affordability. The idea of guiding treatment
through diagnostic testing was also subject to eco-
nomic evaluation. One doctor in Sierra Leone
explained that even where such resources might be
materially available, their unaffordability for patients
precludes their use and thus reliance on antimicro-
bials as a cheaper and faster solution prevails:
‘The only constraint is sometimes the labs are very
expensive, so you send a patient to a lab and they tell
the patient, “Your test costs 250,000 Le[Leones],” the
patient prefers to just go and get the drugs. Whether
that is the condition or not, the patient still prefers
the drug to the test. So, because of the cost, and
sometimes delay. Some labs do delay with test
results.‘ P001 – Sierra Leone
Concerns over the veracity of antibiotics led to pre-
ferences for particular brands of antibiotics over
others, including antibiotics produced in Europe to
those produced in China and the Middle East.
While veterinarians encountered similar issues to
human healthcare professionals regarding availability,
affordability and branding of antimicrobials, they also
recounted specific concerns relating to livestock hus-
bandry. A key concern was antibiotic withdrawal
periods. One Nigerian vet, apprehensive about anti-
biotic residues in eggs for human consumption,
described how he would select an antibiotic which
might not be so effective in the eradication of disease,
but that would have a shorter withdrawal period.
Antimicrobials as care
‘It is frustrating. As a doctor, I am frustrated about it.
I can’t provide the best care that I should be provid-
ing’ D003 – Sierra Leone
‘I have actually asked this question to my seniors,
like you are putting the patient on meropenem right
now without even considering other options, what if
the patient needs another intervention later in his or
her life… but their answer was like, I don’t care
about what will happen in the future, right now
we’re concerned about how to save our patient
now… And they’re also correct in their regards,
right, I mean we cannot really explain to the patient’s
family that we killed their patients just because we
were being very very cautious about the use of anti-
biotics, we cannot explain that.’ DO21 – West Bengal
A concern for both human and animal healthcare
prescribers and dispensers across the study sites was
the lack of available resources for providing care
beyond the provision of antimicrobials. Reliance on
antimicrobials as vehicles of care was a way to accom-
modate the overwhelming ratio of patients to health-
care practitioners, the lack of capacity and
affordability of laboratory facilities, inadequate ward
and clinic supplies, and unreliable patient care out-
side the clinical setting. These combined concerns
were highlighted by a Nigerian doctor, who explains
how these social, economic and political concerns
determine antimicrobial use in the hospital setting:
‘We end up prescribing an empirical antibiotic… to
avoid the progression of the disease, but this is not an
efficient practice, but this is what we are forced to do
because of the circumstances of our work environment,
either because the facilities are overwhelmed by the
number of patients, or the available staff on the ground
are not enough.’ D003 – Nigeria
Antimicrobials as hygiene
‘It’s overflowing with patients. People lie on the floor
actually, we call them floor admissions. It is actually
a term, ‘floor admission’ D021 – West Bengal
‘How can you practice sterile techniques and good
hygiene practices when you have patients lying on
the floor?’ D030-1 Philippines
Antimicrobials were prescribed and dispensed across
the study sites as a replacement for poor hygiene and
sanitation in both the community and the clinical
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setting that facilitated the contracting or spreading of
disease. This spanned diverse concerns from open defe-
cation in the community in West Bengal to cheap
corrosive hand wash in a Vietnamese hospital which
was purportedly reducing frequency of handwashing
among staff. Across all study sites, inadequate facilities
for patient isolation and ventilation in hospital settings
encouraged reliance on antimicrobials to mitigate
cross-infection within and between wards and patients.
Human healthcare professionals also explained that
concerns over high levels of malnutrition among the
population, particularly in children, often led them to
prescribe or dispense antimicrobials as a safety measure
even where a disease episode was unlikely bacterial in
nature. Hygiene and sanitation concerns were mirrored
by veterinarians who stated that poor biosecurity in
livestock rearing facilitated disease and conditioned
reliance on antimicrobials.
Commercial incentives
‘If (a) promoter comes and promotes one drug today
it’s something that we see that for (a) certain number
of days it’s only that drug that gets prescribed.’ P004
– Ethiopia (2)
Interactions with medical representatives were reported
by human and animal healthcare providers across the
study sites but were more commonly lamented by
human healthcare professionals. Researchers observed
the comings and goings ofmedical representatives during
their observations particularly in clinical settings. These
representatives were relied upon for up-to-date informa-
tion on medicines, samples of medicines and opportu-
nities for continuing professional development and
profit. Healthcare professionals across the sites felt med-
ical representatives exercised a high degree of influence
over prescribing and dispensing practices and were con-
cerned that their motives reflected business priorities
rather than concern for patients or for the optimum use
of medicines. The worrying nature of their influential
practice is described here by a pharmacist in Chennai as
motivating practitioners towards particular antibiotic
medicines:
‘Representatives motivate doctors to prescribe more
antibiotics and more expensive ones, higher genera-
tion too. Before doctors just used to give first gen-
eration, amoxicillin but now nobody prescribes basic
antibiotics.‘ P002 – Chennai
Discussion
This research aimed to understand awareness of anti-
microbial resistance and how it related to antimicrobial
use in nine settings in Ethiopia, India, Nigeria,
Philippines, Sierra Leone and Vietnam. We found
high levels of awareness of resistance, but this did not
translate to hesitation to use antibiotics. Rather, we
found evidence of escalation of antibiotic choice in a
context of a lack of information on local resistance
patterns. Prescribing and dispensing was moreover
shaped by acute economic issues at the local level but
also chronic infrastructural issues in health systems that
have been built to rely on the presence of antimicrobials
as a substitute for care and for hygiene. In this scenario,
the role of pharmaceutical representatives is amplified,
and their influence was palpable across settings. These
findings suggest that simply increasing awareness of
AMR will be insufficient to change prescribing and
dispensing without local information on which antibio-
tics do work well, without investment in infrastructure
that allows antimicrobials to be released from their
‘band aid’ role, and without active regulation of phar-
maceutical representatives.
AMR awareness: the knowledge behaviour
conundrum
We found that while professionals were aware of
AMR and the role of antimicrobial use in driving
AMR, this knowledge did not translate into the
desired practice of cautious antimicrobial use. In
fact, we found evidence of awareness of AMR leading
to escalated use of antimicrobials. This has clear
implications for the potential development of resis-
tance and needs to be considered in planning aware-
ness raising campaigns. The reasons that awareness
did not lead to desired practice was very clearly
because numerous other factors affected prescribing
and dispensing, in common across sites. These factors
echo the research of many others who have demon-
strated the influence of economic [25,26], infrastruc-
tural [6,27], commercial [6] and social factors [28]
upon prescribing and dispensing practice and can be
situated within wider anthropological discussions
which posit antimicrobials as vehicles of care [29].
Healthcare practitioners across the study sites related
their practice in ways that resemble ‘tinkering’ and
‘tailoring’ in the provision of medicines [30–32],
which can be understood and problematised as
rational strategies of care [30] within constrained
environments, reflecting not a lack of awareness of
AMR, but a lack of resources to adequately address
AMR in daily practice [26,33,34].
Is this finding surprising? The weight of evidence
listed above would suggest it should not be. But, the
emphasis placed on raising awareness [1], and the con-
tinued mobilisation of the vocabulary of ‘irrational’ pre-
scribing and dispensing by healthcare professionals,
suggests that we continue to imagine a linear causal
relationship between knowledge and practice [35], that
can be fixed through provision of general education. Our
reliance on these linear educational models continues in
public health, despite studies highlighting why they rou-
tinely fail [36]. In the case of antimicrobial prescribing,
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scholars have shown that ‘knowledge may not be the
clue’ [28] and highly publicised examples across topics
such as tobacco [37] and HIV/AIDS [38] demonstrate
that raising awareness or increasing knowledge often
does not change practice in intended ways. Moreover,
our finding that AMR awareness can actually affect pre-
scribing in the opposite way to the intention of awareness
programmes may be understood as counterintuitive, but
it could also reflect the predictable reality that such
campaigns are not received in a vacuum. The unintended
consequences of public health campaigns have been
described across topics [39,40] but are often overlooked
in favour of a focus on desired effects. This has been
understood as a facet of the current paradigm of evi-
dence-based medicine that focuses narrowly on prede-
termined outcomes rather than evaluating more
holistically ‘what happens’ [41]. This points to the need
to go beyond the ‘empty vessel’ assumption that often
underlies awareness campaigns [42]; in policy imple-
mentation it is important to recognise that awareness
raising has the potential to do harm.
Antimicrobials as band aids
Across LMIC settings, access to clean water, hygienic
conditions for defecation, access to adequate nutrition
and the resources to secure livestock from disease trans-
mission remains sporadic and insecure, particularly in
rural areas [6,43]. In the face of these threats to human
and animal health, we found that antimicrobials were
often deployed as a crucial band aid; prescribed and
dispensed as a protective measure to mitigate the effects
of health-compromising environments.
This finding underscores the importance of the link
between hygiene and antimicrobial resistance, which has
been highlighted by the WHO and the Inter-Agency
Coordinating Committee [44]. However, initiatives to
improve hygiene still tend to focus on behavioural stra-
tegies such as hand washing or cleaning, whereas our
results highlight the infrastructural dimensions that anti-
microbials are currently stop-gapping. It is clear from
our findings that hygiene challenges emerge from issues
beyond individuals’ control in their living and working
conditions. Healthcare prescribers and dispensers across
our study sites seem unlikely to change their practices
until they feel more secure that the health and wellbeing
of their patients and the animals of their clients will not
be compromised as a result of their withholding antimi-
crobials. Policy that addresses infection prevention must
address the infrastructural context of hygiene if it intends
to impact prescribing practices.
Medical representatives: big influence, little
regulation
We are not the first to highlight the important role of
medical representatives as a main purveyor of
healthcare information in LMICs and as holding sub-
stantial influence over medical practice [45–48].
However, their roles are barely touched upon in global
policy and national action plans on AMR. While med-
ical and governmental institutions may have legislative
checks or guidelines intended to regulate these rela-
tionships [48] it appears that such checks are largely
absent in daily practice across many LMIC settings.
The influence of these representatives points to a desire
among practitioners for more information and better
access to antimicrobials. Policy must address the need
for information by local practitioners in regulatory
frameworks if reliance on potentially unreliable profit
orientated information sources is to be avoided. More
research is vitally needed to explore not just the role
and influence of medical representatives at the bottom
end of the antimicrobial supply chain, but to interro-
gate further up the chain, acknowledging the multiple
levels, agendas and motivations of the pharmaceutical
industry.
Limitations
The research focused on trained healthcare profes-
sionals and did not capture awareness of AMR or
practices of antimicrobial prescribing and dispensing
among unregistered healthcare providers. In many of
our country settings, the majority of antimicrobial
use is likely to occur among these providers. Our
findings of high AMR awareness and the multiple
other factors affecting practice may not resonate
with these providers. Furthermore, only two of our
study sites included veterinary practitioners and thus
further research is required to understand whether
our findings resonate with veterinary professionals in
other settings. The question of generalisability is
always a complex one for qualitative research. Here,
generating generalisable results through purposive
qualitative study is not achieved by having a repre-
sentative sample but by collecting ideas from a wide
range of people and interrogating these responses in a
way that demonstrates points of similarity and points
of divergence. Finally, pooling responses from quali-
tative interviews conducted in different country set-
tings posed methodological challenges and showed
that ‘awareness of AMR’ is often expressed and com-
municated differently across, as well as within, coun-
try settings. These challenges can be instructive as
they show that we cannot take for granted the mean-
ing of ‘awareness’ as a singular concept.
Conclusion
The problem of rising antimicrobial resistance has
been attributed to rising antimicrobial use in
LMICs [20]. Healthcare professionals are often
charged with ‘injudicious’ practice, which is often
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imagined to be a result of low levels of awareness of
AMR and poor knowledge of the optimal use of
antimicrobials. Our data challenges such assump-
tions, showing high AMR awareness among profes-
sionals across seven settings, and that rationales for
everyday prescribing and dispensing practice reflect
wider social, economic, investment and commercial
factors. In pointing to the contingent and often
precarious environments antimicrobials circulate
in, this paper posits that reliance on antimicrobials
by prescribers, dispensers, patients and clients, is
unlikely to change until the settings in which anti-
microbials remain suspended changes; until ade-
quate resources for providing care and health
facilitating environments for both human and ani-
mal populations are established.
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Paper context
Existing literature on AMR highlights irrational antimicro-
bial prescribing and dispensing and lack of awareness as
crucial problems. There remains a dearth of research asses-
sing awareness of AMR and contexts of antimicrobial
usage. This paper shows high levels of awareness among
healthcare professionals across LMIC settings which linked
to the ready use of next-line antibiotics, and contextual
factors that heavily influenced antimicrobial practice.
Addressing contextual restraints will be as important as
raising awareness in tackling AMR.
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